UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

[X]  Quarterly  Report  Pursuant  To  Section  13 or 15(D) Of The  Securities
     Exchange Act Of 1934

                  For the quarterly period ended June 30, 2010

[ ] Transition  Report Under Section 13 or 15(D) Of The  Securities  Exchange
     Act Of 1934

                  For the transition period from __________ to __________

                        Commission File Number: 000-52883

                          CREATIVE LEARNING CORPORATION
             (Exact name of registrant as specified in its charter)

           Delaware                                 20-4456503
 -------------------------------            -------------------------
 (State or other jurisdiction                   (I.R.S. Employer
     of incorporation or                       Identification No.)
        organization)

                              340 Paseo Reyes Drive
                             St. Augustine, FL 32095
                       ----------------------------------
          (Address of principal executive offices, including Zip Code)


                                 (904)-825-0873
                                 --------------
                (Issuer's telephone number, including area code)

                                 B2 Health, INC.
                            7750 N. Union Blvd., #201
                           Colorado Springs, CO 80920
                      -----------------------------------
          (Former name or former address if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.    Yes [x]   No [ ]

Indicate by check mark whether the registrant has submitted electronically and
posted on its corporate Web site, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files).  Yes [ ] No [ ]

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a small reporting  company.  See
the   definitions   of   "large   accelerated   filer,"   "accelerated   filer,"
"non-accelerated  filer," and "smaller  reporting  company" in Rule 12b-2 of the
Exchange Act.

Large accelerated filer [ ]                 Accelerated filer           [ ]
Non-accelerated filer   [ ]                 Smaller reporting company   [x]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).     Yes? [ ]    No [ X ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest  practicable date:  9,800,000 shares of common stock as
of August 10, 2010.


<PAGE>


                                 B2 Health, Inc.
                          (A Development Stage Company)
                        Consolidated Financial Statements
                                   (Unaudited)


                                TABLE OF CONTENTS



                                                                   Page

CONSOLIDATED FINANCIAL STATEMENTS

Consolidated balance sheets                                          1

Consolidated statements of operation                               2-3

Consolidated statements of cash flows                              4-5

Notes to consolidated financial statements                         6-8






<PAGE>

                                      INC.
                          (A Development Stage Company)
                           CONSOLIDATED BALANCE SHEETS


                                                                    June 30,
                                               Sept. 30,               2010
                                                2009               (Unaudited)
                                             ----------           ------------
                                ASSETS

Current assets
 Cash                                        $     174              $        -
 Inventory                                       3,412                   3,412
 Marketable securities                          12,603                     120
                                            ----------              ----------
       Total current assets                     16,189                   3,532
                                            ----------              ----------
         Other                                       -                       -
                                            ----------              ----------
Total Assets                                $   16,189              $    3,532
                                            ==========              ==========

                       LIABILITIES & STOCKHOLDERS' EQUITY

Current liabilities
 Accounts payable                           $    4,816              $   30,526
 Note payable - related party                   13,875                  17,175
 Accrued interest payable                        1,307                   1,307
                                            ----------              ----------
        Total current liabilities               19,998                  49,008
                                            ----------              ----------
Total Liabilities                               19,998                  49,008
                                            ----------              ----------

Stockholders' Equity
  Preferred stock, $.0001 par value;
     10,000,000 shares authorized; none
     issued and outstanding                          -                       -
  Common stock, $.0001 par value;
     50,000,000 shares authorized;
     775,500 shares issued and outstanding          78                      78
  Additional paid in capital                   247,060                 247,060
  Deficit accumulated during the
     development stage                        (270,799)               (310,379)
  Accumulated other comprehensive
     income (loss)                              19,852                  17,765
                                            ----------              ----------
Total Stockholders' Equity                      (3,809)                (45,476)
                                            ----------              ----------

Total Liabilities and
   Stockholders' Equity                     $   16,189              $    3,532
                                            ==========              ==========



                   The accompanying notes are an integral part
                   of the consolidated financial statements.

                                       1
<PAGE>

                                 B2 HEALTH, INC.
                          (A Development Stage Company)
            CONSOLIDATED STATEMENTS OF INCOME AND COMPRHENSIVE INCOME
                                   (Unaudited)

                                               Three Months      Three Months
                                                   Ended             Ended
                                               June 30, 2009     June 30, 2010
                                              --------------    --------------

Sales                                           $        -        $        -
  Cost of goods sold                                     -                 -
                                                ----------        ----------
Gross profit                                             -                 -
                                                ----------        ----------

Operating  expenses:
  General and administrative                        21,760            21,331
                                                ----------        ----------
                                                    21,760            21,331
                                                ----------        ----------

Gain (loss) from operations                        (21,760)          (21,331)
                                                ----------        ----------
Other operating income:
  Previously written off receivables                     -                 -
                                                ----------        ----------
Gain (loss) from operations                        (21,760)         (21,331)
                                                ----------        ----------
Other income (expense):
  Interest expense                                    (509)                -
  Interest and dividend income                          20                 -
  Realized gain (loss) on securities                11,945                 -
                                                ----------        ----------
                                                    11,456                 -
                                                ----------        ----------

Income (loss) before provision for income taxes    (10,304)          (21,331)
  Provision for income tax                               -                 -
                                                ----------        ----------
  Net income (loss)                             $  (10,304)       $  (21,331)

Other comprehensive income (loss) -
net of tax
  Unrealized gain (loss) on securities               5,433                 -
                                                ----------        ----------

Comprehensive income (loss)                     $   (4,871)       $  (21,331)
                                                ==========        ==========

Net income (loss) per share
  (Basic and fully diluted)                     $    (0.01)       $    (0.03)
                                                ==========        ==========
Weighted average number of
   common shares outstanding                       775,500           775,500
                                                ==========        ==========





           The accompanying notes are an integral part of this report.


                                       2
<PAGE>

                                 B2 HEALTH, INC.
                          (A Development Stage Company)
            CONSOLIDATED STATEMENTS OF INCOME AND COMPRHENSIVE INCOME
                                   (Unaudited)

                                                                March 8, 2006
                              Nine Months       Nine Months      (Inception)
                                 Ended             Ended           Through
                             June 30, 2009     June 30, 2010    June 30, 2010
                            ----------------  ----------------  ---------------

Sales                          $   15,871         $        -       $    95,614
Cost of goods sold                 12,653                  -            87,037
                               ----------         ----------       -----------

Gross profit                        3,218                  -             8,577
                               ----------         ----------       -----------
Operating expenses:
   General and administrative      25,916             45,443           276,713
                               ----------         ----------       -----------
                                   25,916             45,443           276,713
                               ----------         ----------       -----------

Gain (loss) from operations       (25,968)           (45,443)         (268,136)
                               ----------         ----------       -----------
Other operating income:
  Previously written off
  receivables                       7,450              3,300            12,450
                               ----------         ----------       -----------
Gain (loss) from operations       (18,518)           (42,143)         (255,686)
                               ----------         ----------       -----------
Other income (expense):
  Interest expense                 (1,591)                 -            (4,139)
  Interest and dividend income        988                  -             3,806
  Realized gain (loss) on
   securities                     (47,851)             2,563           (54,360)
                               ----------         ----------       -----------
Total other income (expense)      (48,454)             2,563           (54,693)
                               ----------         ----------       -----------

Income (loss) before provision
 for income taxes                 (66,972)           (39,580)         (310,379)
Provision for income tax                -                  -                 -
                               ----------         ----------       -----------
Net income (loss)              $  (66,972)        $  (39,580)      $  (310,379)

Other comprehensive income
 (loss) - net of tax
   Unrealized gain (loss)
   on securities                    8,748             (2,087)           17,765
                               ----------         ----------       -----------

Comprehensive income (loss)    $  (58,224)        $  (41,667)      $  (292,614)
                               ==========         ==========       ===========

Net income (loss) per share
  (Basic and fully diluted)    $    (0.08)        $    (0.05)
                               ==========         ==========

Weighted average number of
 common shares outstanding        775,500            775,500
                               ==========         ==========




                   The accompanying notes are an integral part
                   of the consolidated financial statements.


                                       3
<PAGE>

                                 B2 HEALTH, INC.
                          (A Development Stage Company)
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

                                                                  March 8, 2006
                                  Nine Months     Nine Months      (Inception)
                                    Ended            Ended           Through
                                 June 30, 2009   June 30, 2010    June 30, 2010
                                --------------   -------------    -------------

Cash Flows From Operating
 Activities:
   Net income (loss) during the
   development stage             $   (66,972)      $ (39,580)       $ (310,379)

Adjustments to reconcile net loss
 to net cash provided by (used for)
 operating activities:
   Compensatory stock issuances                                         10,500
   Accounts receivable               (14,171)              -                 -
   Inventory                               -                            (3,412)
   Accounts payable                    2,197          25,710            30,526
   Accrued interest payable                -                             1,307
   Realized (gains) loss on
     sale of securities               47,851               -            56,923
                                  ----------       ---------        ----------

Net cash provided by (used for)
 operating activities                (31,095)        (13,870)         (214,535)
                                  ----------       ---------        ----------

Cash Flows From Investing
 Activities:
    Deferred offering costs                                           (65,862)
    Securities - purchases          (922,269)              -        (1,387,608)
    Securities - sales               850,438          10,396         1,348,330
    Treasury stock purchase                                            (25,000)
                                  ----------       ---------        ----------
Net cash provided by (used for)
 investing activities                (71,831)         10,396          (130,140)
                                  ----------       ---------        ----------


                                                 (Continued On Following Page)


                                       4
<PAGE>

                                 B2 HEALTH, INC.
                          (A Development Stage Company)
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                         (Continued From Previous Page)


                                                                  March 8, 2006
                                  Nine Months     Nine Months      (Inception)
                                    Ended            Ended           Through
                                 June 30, 2009   June 30, 2010    June 30, 2010
                                --------------   -------------    -------------
Cash Flows From Financing
Activities:
  Notes payable - borrowings     $    17,750       $   3,300        $   45,475
  Note payable - payments                                              (28,300)
  Sales of common stock                                                327,500
                                  ----------       ---------        ----------
Net cash provided by (used for)
 financing activities                 17,750           3,300           344,675
                                  ----------       ---------        ----------

Net Increase (Decrease) In Cash      (85,176)           (174)                -

Cash At The Beginning Of The Period   85,842             174                 -
                                  ----------       ---------        ----------

Cash At The End Of The Period     $      666       $       -        $        -
                                  ==========       =========        ==========

Schedule Of Non-Cash Investing
 and Financing Activities

   None

Supplemental Disclosure
   Cash paid for interest         $    1,082       $       -        $        -
   Cash paid for income taxes     $        -       $       -        $        -




                   The accompanying notes are an integral part
                   of the consolidated financial statements.



                                       5
<PAGE>

                                 B2 HEALTH, INC.
                          (A Development Stage Company)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

     B2 Health, Inc. (the "Company"),  was incorporated in the State of Delaware
on March 8,  2006.  The  Company  plans to design  and  manufacture  specialized
chiropractic  tables.  The Company is currently in the development stage and has
no significant operations to date.

Basis of Presentation

     The  accompanying  unaudited  financial  statements  have been  prepared in
accordance  with the  instructions  to Form 10-Q and do not  include  all of the
information and disclosures required by generally accepted accounting principles
for complete financial statements.  All adjustments which are, in the opinion of
management,  necessary for a fair  presentation of the results of operations for
the  interim  periods  have  been  made  and are of a  recurring  nature  unless
otherwise  disclosed herein.  The results of operations for such interim periods
are not necessarily indicative of operations for a full year.

Fiscal year

     The Company has chosen September 30 as a year end.

Principles of consolidation

     The accompanying  consolidated financial statements include the accounts of
B2 Health, Inc. and its wholly owned subsidiary.  All intercompany  accounts and
transactions have been eliminated in consolidation.

Cash and cash equivalents

     The  Company  considers  all highly  liquid  investments  with an  original
maturity of three months or less as cash equivalents.

Accounts receivable

     The Company reviews accounts receivable periodically for collectability and
establishes an allowance for doubtful accounts and records bad debt expense when
deemed necessary.  At March 31, 2010 the Company had no balance in its allowance
for doubtful accounts.

Property and equipment

     Property and equipment are recorded at cost and depreciated  under straight
line or accelerated methods over each item's estimated useful life.

                                       6
<PAGE>

Revenue recognition

     Revenue is recognized on an accrual basis as earned under contract terms.

Use of Estimates

     The  preparation  of financial  statements  in  conformity  with  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions   that  affect  reported  amounts  of  assets  and  liabilities  and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting period. Actual results could differ from those estimates.

Income tax

     The Company  accounts for income  taxes under ASC 740.  Pursuant to ASC 740
deferred taxes are provided on a liability  method  whereby  deferred tax assets
are  recognized for deductible  temporary  differences  and operating loss carry
forwards and deferred  tax  liabilities  are  recognized  for taxable  temporary
differences.  Temporary  differences  are the  differences  between the reported
amounts of assets and liabilities  and their tax bases.  Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management,  it is more
likely than not that some  portion or all of the deferred tax assets will not be
realized.  Deferred tax assets and  liabilities  are adjusted for the effects of
changes in tax laws and rates on the date of enactment.

Net income (loss) per share

     The net income  (loss) per share is  computed  by  dividing  the net income
(loss) by the weighted average number of shares of common outstanding. Warrants,
stock  options,  and common stock  issuable upon the conversion of the Company's
preferred  stock (if any),  are not  included in the  computation  if the effect
would be  anti-dilutive  and would  increase the  earnings or decrease  loss per
share.

Financial Instruments

     The carrying value of the Company's financial  instruments,  including cash
and cash  equivalents  and accrued  payables,  as  reported in the  accompanying
balance sheet, approximates fair value.

Marketable Securities

     Marketable  securities  are  classified  as   available-for-sale   and  are
presented  in the  balance  sheets at fair  market  value.  Gains and losses are
determined using the specific identification method.

NOTE 2.     SUBSEQUENT EVENT

      On July 2, 2010 the Company acquired BFK Franchise Company, LLC, a Nevada
limited liability company formed in May 2009, for 9,000,000 shares of the
Company's common stock.

                                       7
<PAGE>
      BFK, which conducts business under the trade name, BRICKS 4 KIDS(R),
offers programs designed to teach principles of engineering, architecture and
physics to children ages 3-12+ using LEGO(R) bricks. BFK provides classes (both
in school and after school), special events programs and day camps that are
designed to enhance and enrich the traditional school curriculum, trigger young
children's lively imaginations and build self-confidence.


                                       8
<PAGE>



Item 2. Management's  Discussion and Analysis of Financial Condition and Plan of
Operation

      The Company was formed in March 2006 to design, manufacture and sell
chiropractic tables and beds. The Company generated only limited revenue and
essentially abandoned its business plan in March 2008.

      Unless otherwise indicated, any reference to the operations of the Company
includes the operations of BFK.

BUSINESS OF BFK

Lego Bricks

      LEGO(R) is a line of construction toys manufactured by the Lego Group, a
privately held company based in Billund, Denmark. The flagship product, Lego,
consists of colorful interlocking plastic bricks and an accompanying array of
gears, minifigures and various other parts. Lego bricks can be assembled and
connected in many ways to construct such objects as vehicles, buildings, and
even working robots. Anything constructed can then be taken apart, and the
pieces used to make other objects. The toys were originally designed in the
1940s in Europe and have achieved an international appeal, with an extensive
subculture that supports Lego movies, games, video games, competitions, and four
Lego themed amusement parks.

Lego pieces of all varieties are a part of a universal system. Despite variation
in the design and purpose of individual pieces over the years, each remains
compatible in some way with existing pieces. Lego bricks from 1958 still
interlock with those made in 2010, and Lego sets for young children are
compatible with those made for teenagers.

      Bricks, beams, axles, gears, mini figures, and all other parts in the Lego
system are manufactured to an exacting degree of precision. When snapped
together, pieces must have just the right amount of strength and flexibility
mixed together to stick together. They must stay together until pulled apart.
They cannot be too easy to pull apart, or the resulting constructions would be
unstable; they also cannot be too difficult to pull apart, since the disassembly
of one creation in order to build another is part of the Lego appeal.

      Since it began producing plastic bricks, the Lego Group has released
thousands of sets themed around a variety of topics including town and city,
space, robots, pirates, Lego Trains, Racers, Vikings, castles, Bionicle,
dinosaurs, holiday locations, scuba diving and undersea exploration, the wild
west, the Arctic, airports and miners.

      The Lego range has expanded to encompass accessory motors, gears, lights,
sensors, and cameras designed to be used with Lego components. Motors, battery
packs, lights and switches are sold under the name Power Functions. The Technics
line utilizes newer types of interlocking connections that are still compatible
with the older brick type connections. The Technics line can often be motorized
with Power Functions.

                                       9
<PAGE>

      Lego initiated a robotics line of toys called "Mindstorms" in 1998, and
has continued to expand and update this range ever since. The product originated
from a programmable brick developed at the MIT Media Lab and the name is taken
from a paper written by a computer scientist and educator who developed the
educational theory of constructionism, and whose research was at times funded by
the Lego Group.

      The programmable Lego brick which is at the heart of these robotics sets
has undergone several updates and redesigns, with the latest being called the
'NXT' brick, and sold under the brand name of Lego Mindstorms NXT 2.0 or 1.5.
The set includes sensors that detect touch, light, sound and ultrasonic waves,
with several others being sold separately, including an RFID reader. The
intelligent brick can be programmed using software available for both Windows
and Mac computers, and is downloaded onto the brick via Bluetooth.

Current Programs

IN-SCHOOL  FIELD  TRIPS.  One-hour  classes  during  school  hours.  Classes are
correlated to the science for a particular grade level. Teacher guides,  student
worksheets,  and step-by-step instruction are provided.  Recommended fees: $5-$8
per student.

AFTER-SCHOOL  CLASSES.  One  hour,  one  day a week  class  held  after  school.
Recommended fees:  $10-$15 per class per child,  minimum commitment is usually 4
classes.

PRE-SCHOOL  CLASSES.  Classes  can  be  held  in  pre-schools  for  children  of
pre-school ages. Recommended fees; $5-$7 per child.

CLASSES FOR  HOME-SCHOOLED  CHILDREN.  Classes can be held in the home of one of
the parents of a home-schooled child. Recommended fees: $8-$10 per child.

CAMPS.  Normally 3 hours per day for 5 days.  Camps can take place at schools or
at other  child-related  venues.  Children use Lego(R) bricks to explore various
science and math concepts while working in an open,  friendly  environment.  The
material  covered each session varies  depending on students' ages,  experience,
and skill level.  A new project is built each week.  Architectural  concepts are
taught while assembling buildings,  castles and other structures.  Instructional
content includes concepts of friction,  gravity and torque,  scale, gears, axles
and beams.  The curriculum can include the construction of a scaled model of the
children's  school  or the  school  mascot.  The  children  work and  play  with
programmable LEGO(R) bricks along with electric motors,  sensors, system bricks,
and LEGO(R) Technic pieces (i.e.  gears,  axles, and beams).  Recommended  fees:
$125-$150/child.  Children  go home with a small  Lego(R)  project  (cost  about
$5/child)

BIRTHDAY PARTIES. In the home of the birthday child.  Recommended fees: $150 per
party up to 10 children. If over 10 children the fee is $10/child.

SPECIAL EVENTS.  Activities with Lego(R) bricks can be held in various locations
including  church  centers,  lodges,   child-related  venues,  private  schools,
pre-schools,  etc. Program can include parents, grandparents and all children in
the family. Recommended fees: $5 per family.



                                       10
<PAGE>

Operating Units

      BFK operates through Corporate Creativity Centers and franchisees.

       A Corporate Creativity Center is a store-front location, owned and
operated by BFK, where BFK coordinates in school field trips, after school
classes, parties, camps and other programs - as well as the retail sales of
LEGO(R) merchandise.

       As of August 10, 2010 BFK had:

          o    One Corporate  Creativity Center in Florida;
          o    Sixteen franchises in twelve states and one foreign country;

Franchise Program

       A franchisee pays a one-time, non-refundable franchise fee of $22,000
upon the execution of the franchise agreement and is required to pay BFK a
royalty of 7% of the amount received from the operation of the franchise.

       The franchisee is granted an exclusive territory and a license to use the
"Bricks 4 Kidz(R)" name and trademarks in the franchised territory. The
franchisee is required to conform to certain standards of business practices.
Each franchise is run as an independent business and, as such, is responsible
its operation, including employment of adequate staff.

       Franchisees are permitted to assign their franchise provided that BFK
receives advance notice of the proposed assignment, the transferee assumes the
obligations under the franchise agreement, the transferee meets certain
conditions and qualifications, and BFK receives a $5000 transfer fee.

       The term of the franchise is for ten years. BFK has the right to
terminate any franchisee in the event of the franchisee's bankruptcy, a default
under the franchise agreement, or other events. The franchisee has the right to
renew the franchise for an additional ten years if, at the time of renewal, the
franchisee is in good standing and pays a renewal fee in the amount of $5000.


                                       11
<PAGE>


       In addition to the $22,000 franchise fee, a franchisee is advised that an
additional investment of between $8,000 and $23,000 will be required for such
things as equipment and supplies, insurance, marketing and working capital
during the start-up phase of the business.

Capital Requirements

       The Company is in the development stage and has only generated limited
revenue. The Company need additional capital to complete the development of its
franchise business and to fund any operating losses. The Company will attempt to
raise capital through the private sale of its common stock or other securities.

       The Company projects that its capital requirements for the twelve months
ending August 31, 2011 will be as follows:

       Opening new Corporate Creativity Centers in
         Las Vegas, Phoenix, Duval County, Florida,
         and Broward County, Florida                      $320,000
       Advertising                                          60,000
       General and administrative expenses                 320,000
       Miscellaneous and contingency                       356,000

Item 4.  Controls and Procedures.

     (a) The Company  maintains a system of controls and procedures  designed to
ensure that  information  required to be disclosed in reports filed or submitted
under the Securities Exchange Act of 1934, as amended ("1934 Act"), is recorded,
processed,  summarized and reported,  within time periods specified in the SEC's
rules and forms and to ensure that  information  required to be disclosed by the
Company  in the  reports  that it files  or  submits  under  the  1934  Act,  is
accumulated  and  communicated  to  the  Company's  management,   including  its
Principal  Executive  and  Financial  Officer,  as  appropriate  to allow timely
decisions  regarding  required  disclosure.  As of June 30, 2010,  the Company's
Principal  Executive and Financial  Officer  evaluated the  effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on that evaluation, the Principal Executive and Financial Officer concluded that
the Company's disclosure controls and procedures were effective.

     (b) Changes in Internal  Controls.  There were no changes in the  Company's
internal  control over  financial  reporting  during the quarter  ended June 30,
2010, that materially  affected,  or are reasonably likely to materially affect,
its internal control over financial reporting.


                                       12
<PAGE>

                                     PART II

Item 6. Exhibits

Exhibits

  31.1  Certification  pursuant to Section 302 of the  Sarbanes-Oxley Act
        of 2002.

  31.2  Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  32    Certification pursuant to Section 906 of the Sarbanes-Oxley Act.



                                       13
<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                      CREATIVE LEARNING CORPORATION


August 23, 2010                       By: /s/ Brian Pappas
                                          ------------------------------
                                          Brian Pappas, Principal Executive,
                                          Financial and  Accounting Officer





<PAGE>